IL6 and adenocarcinoma: To determine whether circulating interleukin profiles differ between the major pathological subtypes of non-small cell lung cancer (NSCLC), plasma concentrations of IL-1RA, IL-6, IL-8, IL-10, and IL-17A were compared between patients with adenocarcinoma and those with squamous cell carcinoma.